Average Co-Inventor Count = 5.49
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Mirati Therapeutics, Inc. (12 from 38 patents)
2. Takeda Pharmaceutical Company Limited (7 from 1,177 patents)
3. Array Biopharma Inc. (5 from 329 patents)
4. Pfizer Corporation (4 from 4,455 patents)
5. Sgx Pharmaceuticals, Inc. (2 from 17 patents)
6. Astrazeneca Ab (1 from 1,500 patents)
7. Hepatikos Therapeutics, LLC (1 from 1 patent)
27 patents:
1. 12421253 - Tetrahydropyridopyrimidine pan-KRas inhibitors
2. 12398154 - Azaquinazoline pan-KRas inhibitors
3. 12304915 - SOS1 inhibitors
4. 11999753 - Tetrahydropyridopyrimidine pan-KRas inhibitors
5. 11964989 - KRas G12D inhibitors
6. 11702418 - SOS1 inhibitors
7. 11548888 - KRas G12C inhibitors
8. 11492351 - MTA-cooperative PRMT5 inhibitors
9. 11479551 - MTA-cooperative PRMT5 inhibitors
10. 11453683 - KRas G12D inhibitors
11. 10689377 - KRas G12C inhibitors
12. 10654833 - ASK1 isoindolin-1-one inhibitors and methods of use thereof
13. 10647715 - KRas G12C inhibitors
14. 10307414 - Pyridinyl and fused pyridinyl triazolone derivatives
15. 9801872 - Pyridinyl and fused pyridinyl triazolone derivatives